[78] These medications inhibit the 5-reductase enzyme, which, in turn, inhibits the production of DHT, a hormone responsible for enlarging the prostate
The company supports diabetes, hypertension, obesity and musculoskeletal conditions and leans on its multi-condition approach to differentiate itself from competitors
[DOI] [PubMed] [Google Scholar] 8.International Diabetes Federation
In a trial of adult patients with type 2 diabetes, hypoglycemia was reported in 6.2% of Wegovy patients versus 2.5% of placebo patients
The initial dosing regimen of liraglutide is 0.6 mg subcutaneously daily, with the dose increased to up to 3 mg for Saxenda and 1.8 mg for Victoza , usually after one week at the previous dose
This helps in making necessary adjustments to your treatment